Teschke R, Danan G

Idioma: Ingles.
Referencias bibliográficas: 15
Paginas: 324-325
Archivo PDF: 105.92 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Rathi C, Pipaliya N, Patel R, Ingle M, Phadke A, Sawant P. Drug induced liver injury at a tertiary hospital in India: Etiology, clinical features and predictors of mortality. Ann Hepatol 2017; 16: 442-50.

2. Danan G, Bénichou C. Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323-30.

3. Bénichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs - II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993; 46: 1331-6.

4. Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci; Special issue: Drug, herb, and dietary supplement hepatotoxicity 2016; 17: 14. DOI: 10.3390/ijms17010014.

5. Björnsson E, Jacobsen EI, Kalaitzakis E. Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing. J Hepatol 2012; 56: 374-80.

6. Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K, García-Ruiz E, García-Muñoz B, et al, Spanish Group for the Study of Drug-induced Liver Disease. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005; 129: 512-21.

7. Zhu Y, Niu M, Chen J, Zou ZS, Ma ZJ, Liu SH, Wang RL, et al. Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients. J Gastroenterol Hepatol 2016; 31: 1476-82. DOI: 10.1111/jgh.13323.

8. Teschke R, Frenzel C, Wolff A, Eickhoff A, Schulze J. Drug induced liver injury: accuracy of diagnosis in published reports. Ann Hepatol 2014; 13: 248-55.

9. Björnsson ES. Hepatotoxicity by drugs: the most common implicated agents. Int J Mol Sci 2016; 17: 224. DOI: 10.3390/ ijms17020224.

10. Teschke R, Schulze J, Schwarzenboeck A, Eickhoff A, Frenzel C. Herbal hepatotoxicity: suspected cases assessed for alternative causes. Eur J Gastroenterol Hepatol 2013; 25: 1093-8. DOI: 10.1097/MCG.0b013e3283603e89.

11. Zambrone FAD, Corrêa CL, Sampaio do Amaral LM. A critical analysis of the hepatotoxicity cases described in the literature related to Herbalife products. Braz J Pharm Sci 2015; 51. Available at: http://dx.oi.org/10.1590/S1984-82502015 000400004

12. Teschke R, Schwarzenboeck A, Frenzel C, Schulze J, Eickhoff A, Wolff A. The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem. Ann Hepatol 2016; 15: 91-119. Available at: http://www.annalsofhepatology.com.mx/revista/numeros/ 2016/HP161-12-Mystery%20(web)%20(FF_041215V) _PROTEGIDO%20(1).pdf

13. Teschke R, Eickhoff A. The Honolulu Liver disease cluster at the Medical Center: Its mysteries and challenges. Int J Mol Sci 2016, 17(4): 476. DOI: 10.3390/ijms17040476.

14. Teschke R, Eickhoff A. Suspected liver injury and the dilemma of causality. Dig Dis Sci 2017; 62: 1095-8. DOI: 10.1007/ s10620-016-4442-5.

15. Teschke R, Larrey D, Melchart D, Danan G. Traditional Chinese Medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs. Medicines 2016; 3(18). DOI: 10.3390/medicines3030018